The sudden death of Bollywood actress Shefali Jariwala, a long-time user of anti-ageing injections, has reignited concerns in India over quick-fix beauty treatments and a rising toll of cardiac events among seemingly healthy young adults.
Advertisement
Jariwala, 42, died last week at her Mumbai residence after a suspected massive cardiac arrest. According to police, she had been using anti-ageing injectables for several years in addition to routine medication.
Police discovered two boxes of anti-ageing and skin rejuvenation tablets with glutathione and vitamins at her home. Glutathione is not approved in India, and she reportedly underwent various treatments, including intravenous infusions.
The Central Drugs Standard Control Organisation regulates pharmaceuticals in India, ensuring the safety and quality of drugs and cosmetics, and has taken steps to prevent quick-fix beauty treatments in accordance with government guidelines.
While the final autopsy report is still pending, the preliminary findings point to a sudden and severe drop in blood pressure – a common cause of cardiac arrest.
Advertisement
Jariwala’s unexpected death has shocked fans and health professionals, prompting fresh scrutiny of unmonitored therapies and the lifestyle choices of India’s fitness-conscious youth.